Pictet Asset Management (UK)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Pictet Asset Management (UK)’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,742	Closed	-$1.45M	–	1064
2019 Q1	$1.45M	Hold	12,742	–	–	﹤0.01%	888
2018 Q4	$499	Sell	12,742 -268,090	-95%	-$11.6M	﹤0.01%	912
2018 Q3	$15.3M	Buy	280,832 +64,142	+30%	+$4.39M	0.03%	466
2018 Q2	$17.9M	Sell	216,690 -22,713	-9%	-$1.75M	0.04%	418
2018 Q1	$15.9M	Buy	239,403 +66,013	+38%	+$3.81M	0.04%	419
2017 Q4	$8.92M	Buy	173,390 +41,919	+32%	+$3.01M	0.02%	530
2017 Q3	$11.7M	Buy	131,471 +85,607	+187%	+$6.5M	0.03%	464
2017 Q2	$2.34M	Sell	45,864 -1,706	-4%	-$95.3K	0.01%	765
2017 Q1	$2.54M	Sell	47,570 -97,629	-67%	-$5.8M	0.01%	737
2016 Q4	$7.25M	Buy	145,199 +25,141	+21%	+$1.35M	0.03%	512
2016 Q3	$7.21M	Buy	+120,058	New	+$6.92M	0.03%	497

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Pictet Asset Management (UK)'s ONCE Position: Q2 2019 in Review

Pictet Asset Management (UK) sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 12,742 shares — an estimated $1.45M sold.

Pictet Asset Management (UK) first reported a position in ONCE in Q3 2016 and held it in 11 quarters. The position peaked at $17.9M in Q2 2018. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

Pictet Asset Management (UK) reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Pictet Asset Management (UK) sold 12,742 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.45M.
Pictet Asset Management (UK) first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2016 and held it in 11 quarters.
Pictet Asset Management (UK)'s Spark Therapeutics, Inc. Common Stock position peaked at $17.9M in Q2 2018.
194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2019, filed 13 Aug 2019.